Changing trends in bacterial infections: Staphylococcus aureus, bacterial pneumonia, Clostridium difficile.
Changing bacterial diseases in the general population of which HIV practitioners should be aware include: new staphylococcal syndromes caused by community-acquired methicillin-resistant Staphylococcus aureus USA300 strains (eg, necrotizing skin infections, pneumonia, fasciitis); continued high rates of community-acquired pneumonia in the potent antiretroviral therapy era; increase rates and severity of Clostridium difficile-associated disease due to the fluoroquinolone-resistant NAP1 strain, and the new scare from extensively drug-resistant tuberculosis, primarily as a potential threat to health care in Africa. This article summarizes a presentation on important bacterial infections made by John G. Bartlett, MD, at the International AIDS Society-USA course in New York in March 2007.
Bartlett
John G
JG
The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
D017088:AIDS-Related Opportunistic Infections; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016360:Clostridioides difficile / Q000187:drug effects; D015331:Cohort Studies; D017714:Community-Acquired Infections; D003967:Diarrhea / Q000150:complications / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D015658:HIV Infections / Q000150:complications* / Q000382:microbiology; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D018410:Pneumonia, Bacterial / Q000150:complications* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000150:complications* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000382:microbiology
D000900:Anti-Bacterial Agents